PDL BioPharma, Inc. Stock Based Compensation

Stock Based Compensation of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Stock Based Compensation growth rates and interactive chart.


Highlights and Quick Summary

  • Stock Based Compensation for the quarter ending June 29, 2020 was $231 Thousand (a -98.7% decrease compared to previous quarter)
  • Year-over-year quarterly Stock Based Compensation decreased by -89.47%
  • Annual Stock Based Compensation for 2019 was $7.12 Million (a 49.62% increase from previous year)
  • Annual Stock Based Compensation for 2018 was $4.76 Million (a 51.63% increase from previous year)
  • Annual Stock Based Compensation for 2017 was $3.14 Million (a -16.14% decrease from previous year)
  • Twelve month Stock Based Compensation ending June 29, 2020 was $21.9 Million (a -7.84% decrease compared to previous quarter)
  • Twelve month trailing Stock Based Compensation increased by 309.74% year-over-year
Trailing Stock Based Compensation for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
$21.9 Million $23.8 Million $7.12 Million $5.35 Million
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Stock Based Compensation of PDL BioPharma, Inc.

Most recent Stock Based Compensationof PDLI including historical data for past 10 years.

Interactive Chart of Stock Based Compensation of PDL BioPharma, Inc.

PDL BioPharma, Inc. Stock Based Compensation for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $0.23 $17.77
2019 $1.72 $2.19 $2.1 $1.12 $7.12
2018 $-0.06 $2.6 $1.26 $0.96 $4.76
2017 $0.12 $0.94 $0.96 $1.11 $3.14
2016 $1.09 $1.05 $0.81 $0.79 $3.74
2015 $0.7 $0.62 $0.23 $0.5 $2.05
2014 $0.48 $0.41 $0.42 $0.19 $1.5
2013 $0.31 $0.19 $0.22 $0.16 $0.87
2012 $0.26 $0.24 $0.23 $0.2 $0.94
2011 $0.13 $0.25 $-0.04 $0.05 $0.39
2010 $0.14 $0.17 $0.17 $0.66

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.